The Exponent Inc (EXPO) share price is expected to increase by 0.32% over the next year. This is based on calculating the average 12-month share price estimate provided by 4 stock analysts who have covered EXPO. Price targets range from $110 at the low end to $120 at the high end. The current analyst consensus for EXPO is a buy. Please note analyst price targets are not guaranteed and could be missed completely.
Exponent Inc has a total of 4 Wall St Analyst ratings. There are 1 buy ratings, 3 ratings, and 0 sell ratings. Since most analysts have a buy consensus rating, the expectation is that Exponent Inc will outperform the market. Investors shouldn't rely purely on analyst ratings; we encourage investors to also take a look at the fundamental and technical analysis in their due diligence.
These are the latest 20 analyst ratings of EXPO.
Analyst/Firm |
Rating |
Price Target |
Change |
Date |
---|---|---|---|---|
Tobey Sommer Truist Securities | Buy | $120 | Reiterates | Jul 26, 2024 |
Tobey Sommer Truist Securities | Buy | $100 | Maintains | Apr 29, 2024 |
Tobey Sommer Truist Securities | Buy | $95 | Maintains | Feb 2, 2024 |
Tobey Sommer Truist Securities | Buy | $110 | Maintains | Jul 31, 2023 |
Joshua Chan UBS | Neutral | $99 | Initiates | Jun 1, 2023 |
Tobey Sommer Truist Securities | Buy | $120 | Maintains | Apr 5, 2022 |
Tobey Sommer Truist Securities | Buy | $118 | Maintains | Aug 2, 2021 |
Sidoti & Co. | Buy | $94 | Maintains | Jun 2, 2020 |
Sidoti & Co. | Buy | Upgrade | May 13, 2020 | |
Sidoti & Co. | Neutral | $80 | Maintains | May 1, 2020 |
Marc Riddick Sidoti & Co. | Buy | $78 | Upgrade | Mar 19, 2020 |
Sidoti & Co. | Neutral | $74 | Maintains | Feb 7, 2020 |
Sidoti & Co. | Neutral | $72 | Maintains | Oct 3, 2019 |
SunTrust Robinson Humphrey | Buy | $81 | Maintains | Sep 20, 2019 |
DA Davidson | Neutral | Initiates | Aug 29, 2019 | |
SunTrust Robinson Humphrey | Buy | Upgrade | Jan 26, 2018 | |
Cantor Fitzgerald | Buy | Initiates | Aug 26, 2016 |
When did it IPO
1990
Staff Count
975
Country
United States
Sector/Industry
Industrials/Engineering & Construction
CEO
Dr. Catherine Ford Corrigan P.E., Ph.D.
Market Cap
$5.82B
In 2023, EXPO generated $536.8M in revenue, which was a increase of 4.57% from the previous year. This can be seen as a signal that EXPO's business is growing, and its share price could be worth more in the future. However, if the company grows faster (or slower) than expected, this could also have a major impact on the future share price.
Revenue From 2020
Revenue From 2021
Revenue From 2022
Revenue From 2023
Summary - Exponent (EXPO) and Cellebrite DI Ltd. (CLBT) have shown performance metrics relative to their sector this year. Further details on specific performance metrics were not provided.
Why It Matters - Performance comparisons highlight relative strength or weakness, influencing investor sentiment and potential investment decisions for Exponent and Cellebrite relative to their sector.
Summary - Exponent (EXPO) shares are gaining momentum, supported by positive earnings estimate revisions, suggesting potential for further price increases in the near term.
Why It Matters - Rising earnings estimate revisions for Exponent (EXPO) suggest improving financial performance, potentially driving share price appreciation and attracting investor interest.
Summary - The Zacks Consulting Services industry is set for growth due to strong service activities, with IT, FCN, and EXPO identified as key stocks to benefit from this demand.
Why It Matters - Healthy service activities indicate robust demand, suggesting potential growth for Zacks Consulting Services stocks like IT, FCN, and EXPO, which may attract investor interest and drive stock prices up.
Summary - Exponent, Inc. (NASDAQ:EXPO) held its Q2 2024 Earnings Conference Call on July 25, 2024, featuring CEO Catherine Corrigan and CFO Rich Schlenker. Participants included analysts from William Blair, UBS, and Truist.
Why It Matters - The earnings call provides insights into Exponent's financial performance and strategic direction, influencing investor sentiment and stock valuation.
Summary - Exponent, Inc. (Nasdaq: EXPO) will pay a quarterly cash dividend of $0.28 per share on September 20, 2024, to shareholders recorded by September 6, 2024.
Why It Matters - Exponent, Inc.'s declaration of a quarterly cash dividend signals financial stability and commitment to returning value to shareholders, potentially boosting investor confidence and stock demand.
Summary - Exponent, Inc. (Nasdaq: EXPO) announced its Q2 fiscal 2024 financial results for the period ending June 28, 2024. Further details on performance were not provided in the excerpt.
Why It Matters - Exponent, Inc.'s Q2 financial results can impact stock performance, indicating the company's growth, profitability, and market position, influencing investor sentiment and decisions.